Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05272345

Fibromyalgia and Sexual Functıonal Dısorder and Sexual Therapy

Follow-Up Wıth Dıagnosıs Of Fıbromyalgıa In Patıents Wıth Sexual Functıonal Dısorder Evaluatıon Of Sexual Therapy And Post-Therapy Fıbromyalgıa

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
15 Years – 49 Years
Healthy volunteers
Accepted

Summary

investigators aim to re-evaluate the findings of Fibromyalgia in patients whose FSFI scores return to normal levels after sexual therapy, by identifying patients with sexual dysfunction according to the FSFI scale applied in patients investigators followed up with a diagnosis of fibromyalgia, and when investigators consulted with obstetricians.

Detailed description

Apart from routine Fibromyalgia treatments, investigators think that Fibromyalgia patients should be evaluated in detail in terms of sexual dysfunction, and better results will be obtained by adding sexual therapy to the treatment in patients with FSFI score below 26.55. In the current literature review, investigators have seen that there is no study on the evaluation of fibromyalgia before and after sexual therapy. investigators think that our study will be a pioneer in terms of showing the importance of the multidisciplinary approach in the treatment of Fibromyalgia. investigators foresee that sexuality is still a subject that is avoided to be talked about due to the cultural infrastructure of developing countries, and that Fibromyalgia will actually decrease with the regulation of sexual life. investigators believe that more comprehensive studies with this perspective will develop a multidisciplinary approach in Fibromyalgia.

Conditions

Interventions

TypeNameDescription
PROCEDUREsexual therapyIn sexual therapy; A total of 4 sessions of therapy were initiated with the patients, one session per week for 1 month.

Timeline

Start date
2022-02-14
Primary completion
2024-05-14
Completion
2025-12-14
First posted
2022-03-09
Last updated
2024-07-18

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05272345. Inclusion in this directory is not an endorsement.